With reference to the latest market forecast report published by
Transparency Market Research, on the title 'Legalized Cannabis Market: Global
Industry Analysis and Opportunity Assessment 2018-2027', revenue generated from
the global legalized cannabis market has been estimated to be valued around US$ 19.96Bn
in 2018, which is projected to increase at a CAGR of 17.2% to US$ 81.4Bn in
2027, during the forecast period (2018-2027).
Target Segments for Legalized Cannabis
The global legalized cannabis market is segmented on the basis of end
use, form, product, compound, and region. On the basis of end use, the
legalized cannabis market is segmented into medicinal and recreational
cannabis. The recreational end use is anticipated to account for a value share
of 52.3% in the year 2018 owing to increasing number of countries legalizing
cannabis, and growing demographics of youth inclined towards consuming
cannabis.
On the basis of product type, the market for legalized cannabis is
categorized into cannabis herb and cannabis resin. Cannabis herb is expected to
dominate the product type segment with a market share valued at 73.8% in 2018.
The legalized cannabis market is further bifurcated on the basis of form into
whole and processed segment. The raw cannabis market is expected to register a
fuelling CAGR of 17.4% over the forecast period.
On the basis of compound, the legalized cannabis market is divided into
THC dominant, CBD dominant, and balanced THC & CBD. The THC dominant
cannabis is anticipated to account for more than 50% value share of the global
legalized cannabis market on the basis of compound.
Request Sample
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37865
Target Geographies for Legalized Cannabis
The report for the legalized cannabis market has been segmented into
North America, Asia Pacific, Europe, Latin America, and Middle East &
Africa. North America constitutes 63.1% of the market share for legalized
cannabis market in the year 2018. The region is anticipated to register a
bolster CAGR of 18.2% over the forecast period. Legalized cannabis is gaining
market traction in North America due to escalating demand among consumers and
increasing legalized cannabis for medical and recreational uses.
Besides, high private and public investment for research and the
development of safer forms of legalized cannabis for consumption such as oils,
vapes, and tinctures, and other edibles are anticipated to positively reinforce
market growth in the North America. Besides, globally medicinal cannabis is
witnessing a growing demand and countries are rapidly in surge of legalizing
the medical usage of cannabis which is expected to increase the legalized
cannabis multiple folds over the forecast period.
Countries are moving towards legalization of cannabis for recreational
purposes to prevent illegal usage, trafficking, and crime, this in turn is
expected to thrust the growth of recreational cannabis. The ease of
availability of recreational cannabis along with the lengthy purchase and
approval process for medical cannabis prescription is expected to trigger this
change and boost recreational cannabis market.
More Trending Reports
Global Legalized Cannabis Market: Competition
Dashboard
TMR has profiled the most prominent companies which are active in the global
legalized cannabis market, such as Medical Marijuana Inc., Aphria, Inc.,
CannTrust Holdings, Inc., Tilray, Inc., Aurora Cannabis Inc, Terra Tech Corp.,
Cronos Group Inc., VIVO Cannabis Inc., STENOCARE, The Supreme Cannabis Company,
Inc., Cannabis Science Inc., Wayland Group Corp., OrganiGram Holdings Inc, and
Canopy Growth Corporation
Buy Now
https://www.transparencymarketresearch.com/checkout.php?rep_id=37865<ype=S
Comments
Post a Comment